Transgenic mice that express Cre recombinase under control of a skeletal muscle-specific promoter from mef2c

Area of Science:

• Molecular Biology
• Genetics
• Developmental Biology

Background:

• Skeletal muscle gene function is crucial but often studied in models where inactivation leads to embryonic lethality.
• Conditional gene inactivation is essential for studying genes specifically in skeletal muscle.
• Existing methods may not offer the required specificity or timing for skeletal muscle research.

Purpose of the Study:

• To develop a transgenic mouse model for skeletal muscle-specific gene inactivation.
• To create a tool for precisely studying gene function in skeletal muscle.
• To overcome limitations of embryonic lethality in skeletal muscle gene research.

Main Methods:

• Generation of a transgenic mouse line expressing Cre recombinase.
• Utilizing a skeletal muscle-specific promoter from the mef2c gene to drive Cre expression.
• Analysis of Cre expression patterns in various skeletal muscle types and developmental stages.

Main Results:

• Cre recombinase expression was confirmed to be exclusively restricted to skeletal muscle.
• Expression was observed in all skeletal muscle types, including epaxial and hypaxial origins.
• Skeletal muscle-specific Cre expression was present in both fast and slow muscle fibers.
• Expression was detected early in development, indicating broad applicability.

Conclusions:

• The developed transgenic mouse line provides a robust tool for skeletal muscle-specific gene function studies.
• This model enables conditional gene inactivation, circumventing embryonic lethality issues.
• The early and comprehensive skeletal muscle-specific Cre expression facilitates research into gene roles in muscle development and function.